Category Subscribers

New VP For US Chamber IP Center

The United States Chamber of Commerce Global Intellectual Property Center has announced the addition of an executive vice president, joining from the brand-name pharmaceutical industry.

WIPO Hails 2 Millionth International Patent Application

In its slick new office building in Geneva, the World Intellectual Property Organization this week celebrated the 2 millionth patent filing under the Patent Cooperation Treaty, which it manages. In the foyer with white clad windows, a crowd was assembled to hear the praise of the international patent filing system.

Proposals For Single EU Patent Issued; Doubts About EU Patent Court Remain

Legislative proposals for a single European patent emerged from the European Commission this week. If approved by the European Parliament and Council, the measures will make patents granted in one country valid in all participating EU member states and drastically cut the cost of patent protection, the Commission said. Patent lawyers praised the proposals but said the issue of an EU-wide patent litigation court must be resolved first.

Europe Creates Orphan Works Registry, Copyright ID System; Digitises EU Content

A European Commission-backed project to identify copyright holders and define orphan works - whose copyright owners cannot be found - recently presented its results and is heading to a second phase with more partners. The project advances the European effort at digitalising content through the Europeana project, a competing project to the Google Books project.

Superconductivity Is Celebrated This Year, Further Work Needed To Tame It

A hundred years ago, Dutch physicist Heike Kamerlingh Onnes and his student Gilles Holst discovered a property that was to launch decades of fervent research to understand the phenomenon: Superconductivity. Today, researchers are still trying to find ways to use this remarkable property, but are celebrating the centenary of its discovery.

Pharma Industry Seeks To Bring A Fresh Face To Public Health Policy

The research-based pharmaceutical industry is working to bring a fresh face to the international public health policy arena in Geneva, most recently through a new initiative on technology transfer. Working through the industry’s Geneva-based trade association, the effort to be seen in a more positive light comes after years of doubts about the transparency of its involvement in these issues and could change the tenor of international negotiations.